Jeffrey Poulton V. - EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Issuer Symbol
ALNY on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey Poulton V. - trading volume in the past year for ALNYLAM PHARMACEUTICALS, INC.

Holdings reported by Jeffrey Poulton V. for ALNYLAM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 61,805 $20,128,034 $325.67 04 Mar 2026 Direct
Restricted Stock Units 0 $465,762 $244.11 27 Feb 2026 Direct Common Stock
Common Stock 57 $18,369 $322.28 04 Mar 2026 by Managed Account
Stock Option (right to buy) 10,480 02 Mar 2026 Direct Common Stock

Transactions reported by Jeffrey Poulton V. for ALNYLAM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.